Terms: = Lymphoma AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Treatment
17 results:
1. Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (cd32)-dependent Manner.
Takami M; Aoki T; Nishimura K; Tanaka H; Onodera A; Motohashi S
Cancer Res Commun; 2024 Feb; 4(2):446-459. PubMed ID: 38319156
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of fcgr2b expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.
Nowicka M; Hilton LK; Ashton-Key M; Hargreaves CE; Lee C; Foxall R; Carter MJ; Beers SA; Potter KN; Bolen CR; Klein C; Knapp A; Mir F; Rose-Zerilli M; Burton C; Klapper W; Scott DW; Sehn LH; Vitolo U; Martelli M; Trneny M; Rushton CK; Slack GW; Farinha P; Strefford JC; Oestergaard MZ; Morin RD; Cragg MS
Blood Adv; 2021 Aug; 5(15):2945-2957. PubMed ID: 34323958
[TBL] [Abstract] [Full Text] [Related]
3. Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma.
Strefford JC; Nowicka M; Hargreaves CE; Burton C; Davies A; Ganderton R; Hiddemann W; Iriyama C; Klapper W; Latham KV; Martelli M; Mir F; Parker H; Potter KN; Rose-Zerilli MJJ; Sehn LH; Trněný M; Vitolo U; Bolen CR; Klein C; Knapp A; Oestergaard MZ; Cragg MS
Blood Adv; 2021 Aug; 5(15):2935-2944. PubMed ID: 34323957
[TBL] [Abstract] [Full Text] [Related]
4. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
Mondello P; Fama A; Larson MC; Feldman AL; Villasboas JC; Yang ZZ; Galkin I; Svelolkin V; Postovalova E; Bagaev A; Ovcharov P; Varlamova A; Huet S; Tesson B; McGrath KR; Slager S; Link BK; Syrbu S; Novak AJ; Habermann TM; Witzig TE; Nowakowski GS; Salles G; Cerhan JR; Ansell SM
Blood Cancer J; 2021 Jul; 11(7):130. PubMed ID: 34267181
[TBL] [Abstract] [Full Text] [Related]
5. Development of Anti-cd32b Antibodies with Enhanced Fc Function for the treatment of B and Plasma Cell Malignancies.
Lu H; Molony RD; Chen D; Jang S; Wolf B; Ewert S; Flaherty M; Xu F; Isim S; Shim Y; Dornelas C; Balke N; Leber XC; Scharenberg M; Koelln J; Choi E; Ward R; Johnson J; Calzascia T; Isnardi I; Williams JA; Lindenbergh PL; van de Donk NWCJ; Mutis T; Huet H; Lees E; Meyer MJ
Mol Cancer Ther; 2020 Oct; 19(10):2089-2104. PubMed ID: 32847974
[TBL] [Abstract] [Full Text] [Related]
6. Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia.
Natarajan H; Kumar L; Bakhshi S; Sharma A; Velpandian T; Kabra M; Gogia A; Ranjan Biswas N; Gupta YK
Leuk Lymphoma; 2019 Feb; 60(2):418-425. PubMed ID: 30124353
[TBL] [Abstract] [Full Text] [Related]
7. FcγRIIb expression in early stage chronic lymphocytic leukemia.
Bosch R; Mora A; Vicente EP; Ferrer G; Jansà S; Damle R; Gorlatov S; Rai K; Montserrat E; Nomdedeu J; Pratcorona M; Blanco L; Saavedra S; Garrido A; Esquirol A; Garcia I; Granell M; Martino R; Delgado J; Sierra J; Chiorazzi N; Moreno C
Leuk Lymphoma; 2017 Nov; 58(11):2642-2648. PubMed ID: 28372509
[TBL] [Abstract] [Full Text] [Related]
8. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
Vieyra-Garcia PA; Wei T; Naym DG; Fredholm S; Fink-Puches R; Cerroni L; Odum N; O'Malley JT; Gniadecki R; Wolf P
Clin Cancer Res; 2016 Jul; 22(13):3328-39. PubMed ID: 26851186
[TBL] [Abstract] [Full Text] [Related]
9. Immunotherapy targeting inhibitory Fcγ receptor IIB (cd32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.
Williams EL; Tutt AL; Beers SA; French RR; Chan CH; Cox KL; Roghanian A; Penfold CA; Butts CL; Boross P; Verbeek JS; Cragg MS; Glennie MJ
J Immunol; 2013 Oct; 191(8):4130-40. PubMed ID: 24026082
[TBL] [Abstract] [Full Text] [Related]
10. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract] [Full Text] [Related]
11. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions.
Sakagawa H; Miyazaki T; Fujihara M; Sato S; Yamaguchi M; Fukai K; Morioka M; Kato T; Azuma H; Ikeda H
Transfusion; 2007 Jan; 47(1):154-61. PubMed ID: 17207244
[TBL] [Abstract] [Full Text] [Related]
12. cd32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma.
Rankin CT; Veri MC; Gorlatov S; Tuaillon N; Burke S; Huang L; Inzunza HD; Li H; Thomas S; Johnson S; Stavenhagen J; Koenig S; Bonvini E
Blood; 2006 Oct; 108(7):2384-91. PubMed ID: 16757681
[TBL] [Abstract] [Full Text] [Related]
13. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma.
Weng WK; Levy R
J Clin Oncol; 2003 Nov; 21(21):3940-7. PubMed ID: 12975461
[TBL] [Abstract] [Full Text] [Related]
14. Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines.
Flieger D; Renoth S; Beier I; Sauerbruch T; Schmidt-Wolf I
Cell Immunol; 2000 Aug; 204(1):55-63. PubMed ID: 11006018
[TBL] [Abstract] [Full Text] [Related]
15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domains.
Haagen IA; Geerars AJ; Bast EJ; de Gast GC; van de Winkel JG; de Lau WB
Ther Immunol; 1994 Oct; 1(5):279-87. PubMed ID: 7584502
[TBL] [Abstract] [Full Text] [Related]
17. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
Repp R; Valerius T; Sendler A; Gramatzki M; Iro H; Kalden JR; Platzer E
Blood; 1991 Aug; 78(4):885-9. PubMed ID: 1714327
[TBL] [Abstract] [Full Text] [Related]
